Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art. (12th August 2020)

• Record Type: Journal Article
• Authors: Vatrella, Alessandro; Maglio, Angelantonio; Pelaia, Corrado; Pelaia, Girolamo; Vitale, Carolina
• Is Part Of: Expert opinion on pharmacotherapy. Volume 21:Number 12(2020)
• Page Start: 1505
• Page End: 1515
• Publication Date: 2020-08-12
• Subjects: Acute asthma -- anticholinergics -- asthma exacerbation -- asthma therapy -- beta 2 agonists -- corticosteroids -- CAS -- critical asthma syndrome -- severe asthma; Chemotherapy -- Periodicals; 615.5805
• DOI: 10.1080/14656566.2020.1766023
• Languages: English
• ISSNs: 1465-6566

Abstract

ABSTRACT: Introduction: 'Critical Asthma Syndrome' (CAS) is an umbrella term proposed to include several forms of asthma, responsible for acute and life-threatening exacerbations. CAS requires urgent and adequate supportive and pharmacological treatments to prevent serious outcomes. Areas covered: The purpose of this review is to discuss current knowledge on the pharmacotherapeutic strategies for treatment of CAS. Expert opinion: Airflow limitation, airway wall edema, and mucus plugs are the pathophysiological targets of pharmacological therapies. Strategies to achieve these goals are based on the use of various classes of drugs. Inhaled beta2-agonists are the mainstay of the initial therapy of CAS. Inhaled anticholinergic agents may be considered in the treatment of CAS in addition to beta 2 agonists. Systemic corticosteroids should be administered as soon as possible in order to counteract airway inflammation and restore normal airway sensitivity. The effectiveness of pharmacological therapies in CAS is linked not only to the timely use of drugsbut also to the dosage and route of administration. Early recognition and aggressive treatment are essential for the management of CAS; however, prevention is the best cure. Although significant progress has been made, further efforts are needed to implement an optimal exacerbation prevention strategy.